Vancomycin-resistant enterococcal infections.
暂无分享,去创建一个
[1] R A Weinstein,et al. A Comparison of the Effect of Universal Use of Gloves and Gowns with That of Glove Use Alone on Acquisition of Vancomycin-Resistant Enterococci in a Medical Intensive Care Unit , 1996, Annals of Internal Medicine.
[2] R. Eng,et al. Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: association with antibiotic usage. , 1998, American journal of infection control.
[3] M. Evans,et al. Vancomycin Use in a University Medical Center: Comparison With Hospital Infection Control Practices Advisory Committee Guidelines , 1996, Infection Control & Hospital Epidemiology.
[4] J. Lemeland,et al. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. , 1995, The Journal of infectious diseases.
[5] S. Nachman,et al. Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an antibiotic cure. , 1995, Microbial Drug Resistance.
[6] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[7] P. Courvalin,et al. VanD-type glycopeptide-resistant Enterococcus faecium BM4339 , 1997, Antimicrobial agents and chemotherapy.
[8] F. Tenover,et al. Detection of vancomycin-resistant enterococci in fecal samples by PCR , 1997, Journal of clinical microbiology.
[9] F. Moreno,et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] A. Bisno,et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. , 1995, JAMA.
[11] R. Leclercq,et al. Resistance to glycopeptides in enterococci. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] D. Armstrong,et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. , 1996, The Pediatric infectious disease journal.
[13] B. Murray,et al. Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci , 1994, Antimicrobial Agents and Chemotherapy.
[14] D. Sexton,et al. Resistant Enterococci: A Prospective, Study of Prevalence, Incidence, and Factors Associated With Colonization in a University Hospital , 1996, Infection Control & Hospital Epidemiology.
[15] W. Bilker,et al. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] S. Ricke,et al. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States , 1996, Antimicrobial agents and chemotherapy.
[17] G. Eliopoulos,et al. In vitro activities in new oxazolidinone antimicrobial agents against enterococci , 1996, Antimicrobial agents and chemotherapy.
[18] C. Walsh,et al. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. , 1991, Biochemistry.
[19] D. Thompson,et al. Historical Yearly Usage of Vancomycin , 1998, Antimicrobial Agents and Chemotherapy.
[20] F. Allerberger,et al. In-vitro activity of fosfomycin against vancomycin-resistant enterococci. , 1999, The Journal of antimicrobial chemotherapy.
[21] J. Lemeland,et al. In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci , 1995, Antimicrobial agents and chemotherapy.
[22] J. Warren,et al. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] D. Pegues,et al. Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital , 1997, Journal of clinical microbiology.
[24] A. Tomasz,et al. Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospital. , 1996, Microbial drug resistance.
[25] M. Arthur,et al. Requirement of the VanY and VanX D,D‐peptidases for glycopeptide resistance in enterococci , 1998, Molecular microbiology.
[26] G. Wormser,et al. Bloodstream infections with vancomycin-resistant enterococci. , 1996, Archives of internal medicine.
[27] L. Bopp,et al. Genetic Analysis of Multiple Vancomycin-ResistantEnterococcus Isolates Obtained Serially from Two Long-Term-Care Patients , 1998, Journal of Clinical Microbiology.
[28] M. Arthur,et al. The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction , 1997, Journal of bacteriology.
[29] B. Murray. The life and times of the Enterococcus , 1990, Clinical Microbiology Reviews.
[30] B. Farr,et al. Disinfection of Hospital Rooms Contaminated With Vancomycin-Resistant Entemcocms faecium , 1998, Infection Control & Hospital Epidemiology.
[31] G. Wormser,et al. A semiquantitative analysis of the fecal flora of patients with vancomycin-resistant enterococci: colonized patients pose an infection control risk. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] T. L. Hodges,et al. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens , 1992, Antimicrobial Agents and Chemotherapy.
[33] P. Vandamme,et al. Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands. , 1998, The Journal of antimicrobial chemotherapy.
[34] M. Zervos,et al. A New High-Level Gentamicin Resistance Gene,aph(2")-Id, in Enterococcus spp , 1998, Antimicrobial Agents and Chemotherapy.
[35] P. Murray,et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis , 1989, Antimicrobial Agents and Chemotherapy.
[36] A. Simor,et al. Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] G. Satta,et al. Intrinsic penicillin resistance in enterococci. , 1996, Microbial drug resistance.
[38] B. Murray,et al. Beta-lactamase-producing enterococci , 1992, Antimicrobial Agents and Chemotherapy.
[39] S. Handwerger,et al. Mobilization of vancomycin resistance by transposon-mediated fusion of a VanA plasmid with an Enterococcus faecium sex pheromone-response plasmid. , 1996, Gene.
[40] W. Lynn,et al. Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin , 1994, The Lancet.
[41] R. Weinstein,et al. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] W. C. Miller,et al. Relapsing Native‐Valve Enterococcal Endocarditis: A Unique Cure with Oral Ciprofloxacin Combination Drug Therapy , 1991, Journal of clinical pharmacology.
[43] J. Duval,et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.
[44] V. Yu,et al. Treatment Options for Chronic Prostatitis due to Vancomycin-Resistant Enterococcus faecium , 1998, European Journal of Clinical Microbiology and Infectious Diseases.
[45] L. Peterson,et al. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium. , 1995, Microbial drug resistance.
[46] J. Boyce,et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance , 1994, Journal of clinical microbiology.
[47] B. Cookson,et al. Diversity of VanA Glycopeptide Resistance Elements in Enterococci from Humans and Nonhuman Sources , 1998, Antimicrobial Agents and Chemotherapy.
[48] N. Mobarakai,et al. Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium. , 1995, The Journal of antimicrobial chemotherapy.
[49] J. S. Daly,et al. High-dose ampicillin plus streptomycin for treatment of a patient with severe infection due to multiresistant enterococci. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[50] R. Wenzel,et al. Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital. , 1986, Archives of internal medicine.
[51] R. Gaynes,et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. , 1992 .
[52] G. Woods,et al. Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers , 1992, Annals of Internal Medicine.
[53] R. Wenzel,et al. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. , 1989, American journal of infection control.
[54] G. Eliopoulos,et al. Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci , 1992, Antimicrobial Agents and Chemotherapy.
[55] W. Witte,et al. Glycopeptide-resistant Enterococcus faecium outside Hospitals: a commentary. , 1995, Microbial drug resistance.
[56] G. Trenholme,et al. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. , 1993, The Journal of infectious diseases.
[57] L. Adinolfi,et al. Successful Treatment with Ampicillin and Fluoroquinolones of Human Endocarditis due to High-Level Gentamicin-Resistant Enterococci , 1998, European Journal of Clinical Microbiology and Infectious Diseases.
[58] N. Rolando,et al. Serious infections caused by multiply-resistant Enterococcus faecium. , 1995, Microbial drug resistance.
[59] G. Talbot,et al. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium , 1999 .
[60] B. Murray,et al. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis , 1994, Antimicrobial Agents and Chemotherapy.
[61] F. Cockerill,et al. DNA sequence resembling vanA and vanB in the vancomycin-resistant biopesticide Bacillus popilliae. , 1998, The Journal of infectious diseases.
[62] R N Jones,et al. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group. , 1995, Diagnostic microbiology and infectious disease.
[63] P. Courvalin,et al. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. , 1994, FEMS microbiology letters.
[64] L. Riley,et al. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] R. Gaynes,et al. Major trends in the microbial etiology of nosocomial infection. , 1991, The American journal of medicine.
[66] B. Fantin,et al. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis , 1997, Antimicrobial agents and chemotherapy.
[67] G. Eliopoulos,et al. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis , 1990, Antimicrobial Agents and Chemotherapy.
[68] P. Courvalin,et al. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens , 1994, Antimicrobial Agents and Chemotherapy.
[69] A. Goldstone,et al. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. , 1999, The Journal of antimicrobial chemotherapy.
[70] J. Mainardi,et al. Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance. , 1998, The Journal of infectious diseases.
[71] P. Sisson,et al. Therapeutic beds: the Trojan horses of the 1990s? , 1994, The Lancet.
[72] E. Dejesus,et al. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model , 1996, Antimicrobial agents and chemotherapy.
[73] B. Murray,et al. beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis. , 1987, The Journal of infectious diseases.
[74] F. Aarestrup,et al. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster , 1996, Antimicrobial agents and chemotherapy.
[75] L. Peterson,et al. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] B. Murray,et al. High-level resistance to gentamicin in clinical isolates of enterococci. , 1983, The Journal of infectious diseases.
[77] N. Schupf,et al. Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. , 1998 .
[78] N. Woodford,et al. VANCOMYCIN-RESISTANT ENTEROCOCCI , 1988, The Lancet.
[79] M. Rupp,et al. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period , 1997, Antimicrobial agents and chemotherapy.
[80] F. Tenover,et al. Characterization of glycopeptide-resistant enterococci from U.S. hospitals , 1993, Antimicrobial Agents and Chemotherapy.
[81] G. Wormser,et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. , 1995, The Journal of infectious diseases.
[82] S. Handwerger,et al. Persistence of vancomycin-resistant Enterococcus faecium gastrointestinal tract colonization in antibiotic-treated mice. , 1996, Microbial drug resistance.
[83] J. Fung,et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[84] C Brennen,et al. Vancomycin‐Resistant Enterococcus faecium in a Long‐Term Care Facility , 1998, Journal of the American Geriatrics Society.
[85] D. Dunn,et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[86] M. Arthur,et al. Mechanisms of glycopeptide resistance in enterococci. , 1996, The Journal of infection.
[87] R. Leclercq,et al. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. , 1996, The Journal of infectious diseases.
[88] M. Levison,et al. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium , 1993, Antimicrobial Agents and Chemotherapy.
[89] J. Elion,et al. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital , 1991, Journal of clinical microbiology.
[90] W. Scheld,et al. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. , 1997, Archives of internal medicine.
[91] J. Morris,et al. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[92] M. Cohen,et al. In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci , 1995, Antimicrobial agents and chemotherapy.
[93] D. Maki,et al. Enterococcal Bacteremia: Clinical Features, the Risk of Endocarditis, and Management , 1988, Medicine.
[94] P. Courvalin,et al. VanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405 , 1999, Antimicrobial Agents and Chemotherapy.
[95] R. Bégué,et al. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol. , 1999, The Pediatric infectious disease journal.
[96] R. Weinstein,et al. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. , 1999, The Journal of infectious diseases.
[97] C. Stratton,et al. Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. , 1996, The Journal of infectious diseases.
[98] P. Brennan,et al. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[99] R. Moellering,et al. The enterococcus: "putting the bug in our ears". , 1987, Annals of internal medicine.
[100] T. Rakowski,et al. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[101] G. Eliopoulos,et al. Vancomycin-resistant Enterococcus faecium in hospitalized children. , 1992 .
[102] K. Singh,et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[103] G. Papanicolaou,et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[104] R. Wenzel,et al. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[105] Ronald N. Jones,et al. Molecular Analysis of Tn1546 inEnterococcus faecium Isolated from Animals and Humans , 1998, Journal of Clinical Microbiology.
[106] W. Noble,et al. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. , 1992, FEMS microbiology letters.
[107] A. C. McIntosh,et al. Isolation of vancomycin-resistant enterococci from animal feed in USA , 1999, The Lancet.
[108] J. Duval,et al. Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145 , 1993, Antimicrobial Agents and Chemotherapy.
[109] M. Millar,et al. Successful use of tetracycline as therapy of an immunocompromised patient with septicaemia caused by a vancomycin-resistant enterococcus. , 1997, Journal of Antimicrobial Chemotherapy.
[110] R. Wenzel,et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[111] D. Goldmann,et al. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. , 1995, Pediatric clinics of North America.
[112] J. Morris,et al. Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center , 1995, Annals of Internal Medicine.
[113] J. Bates,et al. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. , 1994, The Journal of antimicrobial chemotherapy.
[114] Natural history of colonization with vancomycin-resistant Enterococcus faecium. , 1995, Infection control and hospital epidemiology.
[115] L. Jensen,et al. Vancomycin-resistant enterococci in turkeys and farmers. , 1997, The New England journal of medicine.
[116] J. Duval,et al. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium , 1989, Antimicrobial Agents and Chemotherapy.
[117] P. Courvalin,et al. Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. , 1996, Gene.
[118] J. Chia,et al. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[119] D. Landman,et al. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[120] B. Fantin,et al. Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis. , 1997, The Journal of infectious diseases.
[121] G. Eliopoulos. Aminoglycoside resistant enterococcal endocarditis. , 1993, Infectious disease clinics of North America.
[122] L. Rice,et al. Genetic Linkage and Cotransfer of a Novel,vanB-Containing Transposon (Tn5382) and a Low-Affinity Penicillin-Binding Protein 5 Gene in a Clinical Vancomycin-Resistant Enterococcus faecium Isolate , 1998, Journal of bacteriology.
[123] P. Linden,et al. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort. , 1997, The Journal of antimicrobial chemotherapy.
[124] R. Eng,et al. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. , 1994, Diagnostic microbiology and infectious disease.
[125] J. Duval,et al. Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci , 1991, Antimicrobial Agents and Chemotherapy.
[126] P. Berche,et al. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis , 1997, Antimicrobial agents and chemotherapy.
[127] G. Eliopoulos,et al. Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium , 1997, Antimicrobial agents and chemotherapy.
[128] M. Zervos,et al. Treatment of Vancomycin-Resistant Enterococcus faeciumwith RP 59500 (Quinupristin-Dalfopristin) Administered by Intermittent or Continuous Infusion, Alone or in Combination with Doxycycline, in an In Vitro Pharmacodynamic Infection Model with Simulated Endocardial Vegetations , 1998, Antimicrobial Agents and Chemotherapy.
[129] G. Losonsky,et al. Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[130] G. Wormser,et al. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium , 1995, Antimicrobial agents and chemotherapy.
[131] T. Schiano,et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. , 1998, Transplantation.
[132] G. Eliopoulos,et al. In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms , 1993, Antimicrobial Agents and Chemotherapy.
[133] C. Flexner,et al. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[134] A. Ambergen,et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. , 1998, Archives of internal medicine.
[135] S. Migliaresi,et al. Combination of co-trimoxazole and ciprofloxacin as therapy of a patient with infective endocarditis caused by an enterococcus highly resistant to gentamicin. , 1997, The Journal of antimicrobial chemotherapy.
[136] J. Conly,et al. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[137] F. Moreno,et al. An old antibiotic for a new multiple-resistant Enterococcus faecium? , 1994, Diagnostic microbiology and infectious disease.
[138] P. Courvalin,et al. Genetics of glycopeptide resistance in enterococci. , 1996, Microbial drug resistance.
[139] H. Claus,et al. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. , 1995, FEMS microbiology letters.
[140] Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. , 1995, JAMA.
[141] A. Rendo,et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci , 1993, Journal of clinical microbiology.